These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 5755333
1. [Results of treatment with vinblastine of various neoplasms and proliferative syndromes of the lymphoid tissue]. Polubiec A, Kolakowska-Polubiec K. Wiad Lek; 1968 Oct 01; 21(19):1739-42. PubMed ID: 5755333 [No Abstract] [Full Text] [Related]
2. [The role of vinblastine in the treatment of malignant lymphomas]. Eridani S, Esposito R, Ponti GB, Giangrande A. Cancro; 1968 Oct 01; 21():Suppl 6:102+. PubMed ID: 4906143 [No Abstract] [Full Text] [Related]
3. Recent advances in chemotherapy of lymphoma. Lenhard RE, Owens AH. Johns Hopkins Med J; 1967 Aug 01; 121(2):136-40. PubMed ID: 5340335 [No Abstract] [Full Text] [Related]
4. Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma. Stutzman L, Ezdinli EZ, Stutzman MA. JAMA; 1966 Jan 17; 195(3):173-8. PubMed ID: 5322863 [No Abstract] [Full Text] [Related]
5. [Results of polychemotherapy in neoplasms of the lymphoreticular system]. Stenzel L, Krug K, Schingnitz G. Z Gesamte Inn Med; 1973 May 01; 28(9):Suppl 9:134-6. PubMed ID: 4199963 [No Abstract] [Full Text] [Related]
6. [Effectiveness of polychemotherapeutic treatments of lymphoproliferative diseases]. Cajozzo A, Citarrella P, Carreca I, D'Eredità F. Haematologica; 1970 May 01; 55(7):465-70. PubMed ID: 4996520 [No Abstract] [Full Text] [Related]
7. [Vincaleukoblastine in the therapy of malignant neoplasms]. Rotolo V. Friuli Med; 1968 May 01; 23(1):31-52. PubMed ID: 4910040 [No Abstract] [Full Text] [Related]
8. [Experience with vinblastine in the treatment of lymphoblastomas]. Capretti G. Cancro; 1968 May 01; 21():Suppl 6:93-7. PubMed ID: 4906146 [No Abstract] [Full Text] [Related]
9. Treatment of lymph-node tumours with Vinblastin. Eckhardt S. Ther Hung; 1969 May 01; 17(2):57-9. PubMed ID: 5820144 [No Abstract] [Full Text] [Related]
10. [Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy]. Dubois-Ferrière H. Schweiz Med Wochenschr; 1967 Nov 04; 97(44):1478-9. PubMed ID: 5631771 [No Abstract] [Full Text] [Related]
11. Vinblastine treatment of malignant lymphomas. Klener P, Donner L, Neuwirtová R, Ort J. Neoplasma; 1971 Nov 04; 18(5):505-11. PubMed ID: 4940935 [No Abstract] [Full Text] [Related]
12. [Clinical experience in the treatment of malignant lymphomas with Vinca rosea alkaloids]. Prato V, Mazza U, Uslenghi E, Battistini V, Bianco G. Cancro; 1968 Nov 04; 21():Suppl 6:79-85. PubMed ID: 4906145 [No Abstract] [Full Text] [Related]
13. Initial clinical experience with vinglycinate sulfate, a molecular modification of vinblastine. Armstrong JG, Dyke RW, Fouts PJ, Hawthorne JJ, Jansen CJ, Peabody AM. Cancer Res; 1967 Feb 04; 27(2):221-7. PubMed ID: 5335120 [No Abstract] [Full Text] [Related]
14. Cytotoxic agents in the treatment of malignant disease. Br Med J; 1968 Nov 16; 4(5628):438-9. PubMed ID: 4972069 [No Abstract] [Full Text] [Related]
15. Hodgkin's disease and some solid tumours. Jelliffe AM. Proc R Soc Med; 1966 Dec 16; 59(12):1261-8. PubMed ID: 5955849 [No Abstract] [Full Text] [Related]
16. Phase II study of vindesine in patients with Hodgkin's disease, lymphoma, and breast cancer. Gad-El-Mawla N, Hamza MR, El-Serafi M, El-Khoudary A, Aboul-Einein M, El-Demerdash S. Cancer Treat Rep; 1983 Mar 16; 67(3):316-7. PubMed ID: 6831481 [No Abstract] [Full Text] [Related]
17. Use of vinblastine for maintenance therapy in malignant lymphomas. Klener P, Donner L, Ort J. Neoplasma; 1974 Mar 16; 21(3):323-9. PubMed ID: 4608740 [No Abstract] [Full Text] [Related]